News & insights
Date: October 2014 | Client: Medicines Patent Pool (MPP) | Sector: Global health | Market dynamics, supply & access | Expertise: Health economics & evaluation
Review of Unitaid’s Medicines Patent Pool (MPP)
The Medicines Patent Pool (MPP) is an independent non-profit Swiss Foundation established in July 2010 with the objective of providing patients in low and middle-income countries with increased access to quality, safe, efficacious, appropriate and affordable health products, through a voluntary patent pool mechanism. CEPA undertook a review to closely assess the strategic direction, positioning and operations of the MPP; draw lessons from the MPP’s experience to date; and provide recommendations for improved performance.
The evaluation conclusions and recommendations were presented to the Unitaid Board in June 2014 to inform their decision on future funding to the MPP. CEPA used a mixed methods approach, including a desk-based review of relevant documentation and structured interviews with a range of stakeholders (including Unitaid, MPP, pharmaceutical industry players, civil society organisations) to draw any relevant lessons for the MPP.
To find out more, please contact our experts listed below.
